Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

Chamira Rodrigo, Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Tricia M. Mckeever, Caroline L. Trotter, Mary Slack, Robert George, Wei Shen Lim
European Respiratory Journal 2015 45: 1632-1641; DOI: 10.1183/09031936.00183614
Chamira Rodrigo
1Dept of Respiratory Medicine, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Bewick
1Dept of Respiratory Medicine, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Sheppard
2Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England, Microbiology Services Division, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia Greenwood
1Dept of Respiratory Medicine, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tricia M. Mckeever
3Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline L. Trotter
4Disease Dynamics Unit, Dept of Veterinary Medicine, University of Cambridge, Cambridge, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Slack
2Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England, Microbiology Services Division, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert George
2Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England, Microbiology Services Division, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Shen Lim
1Dept of Respiratory Medicine, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 45 no. 6 1632-1641
DOI 
https://doi.org/10.1183/09031936.00183614
PubMed 
25792633

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received October 4, 2014
  • Accepted December 16, 2014
  • Published online May 31, 2015.

Article Versions

  • previous version (March 18, 2015 - 23:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2015

Author Information

  1. Chamira Rodrigo1,
  2. Thomas Bewick1,
  3. Carmen Sheppard2,
  4. Sonia Greenwood1,
  5. Tricia M. Mckeever3,
  6. Caroline L. Trotter4,
  7. Mary Slack2,
  8. Robert George2 and
  9. Wei Shen Lim1
  1. 1Dept of Respiratory Medicine, City Hospital Campus, Nottingham University Hospitals NHS Trust, Nottingham, UK
  2. 2Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England, Microbiology Services Division, London, UK
  3. 3Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
  4. 4Disease Dynamics Unit, Dept of Veterinary Medicine, University of Cambridge, Cambridge, UK
  1. C. Rodrigo, Dept of Respiratory Medicine, David Evans Building, City Hospital Campus, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham. NG51PB, UK. E-mail: chamira{at}doctors.org.uk
View Full Text

Funding

  • Pfizer

  • National Institute for Health Research

    BRF-2011-017

Article usage

Article usage: March 2015 to December 2022

AbstractFullPdf
Mar 20154004182
Apr 20152737176
May 20153134451
Jun 20151969146176
Jul 20153361437
Aug 20151971726
Sep 20151472928
Oct 2015814123
Nov 2015813721
Dec 2015138149
Jan 2016692216
Feb 2016742426
Mar 20161052150
Apr 20161252480
May 2016511415
Jun 2016531712
Jul 2016561111
Aug 201672157
Sep 2016411813
Oct 2016861510
Nov 201675138
Dec 2016104133
Jan 201763926
Feb 201744518
Mar 201764319
Apr 201753214
May 201714448
Jun 201784015
Jul 201763514
Aug 201783816
Sep 201784416
Oct 201775819
Nov 201736426
Dec 201734312
Jan 201826524
Feb 201835319
Mar 201873636
Apr 201865235
May 201855324
Jun 201824420
Jul 201813614
Aug 201825716
Sep 201864725
Oct 201826323
Nov 201877915
Dec 201835514
Jan 201924916
Feb 201928717
Mar 2019417417
Apr 2019520217
May 2019314716
Jun 2019124023
Jul 2019346718
Aug 20192298729
Sep 2019491619
Oct 2019786328
Nov 2019564722
Dec 2019239416
Jan 20201647
Feb 202027715
Mar 202069642
Apr 202026417
May 202037814
Jun 202065320
Jul 202045421
Aug 202066130
Sep 2020394817
Oct 202047222
Nov 202076420
Dec 202010614
Jan 202177920
Feb 202149812
Mar 2021710819
Apr 2021410736
May 202176822
Jun 202146413
Jul 202155630
Aug 202196622
Sep 2021115323
Oct 202136422
Nov 202143924
Dec 202126435
Jan 202295723
Feb 2022134811
Mar 202242296
Apr 2022213526
May 202255615
Jun 202253419
Jul 202233811
Aug 202243113
Sep 202243621
Oct 202259810
Nov 202236712
Dec 20223211

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 45 Issue 6 Table of Contents
European Respiratory Journal: 45 (6)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Chamira Rodrigo, Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Tricia M. Mckeever, Caroline L. Trotter, Mary Slack, Robert George, Wei Shen Lim
European Respiratory Journal Jun 2015, 45 (6) 1632-1641; DOI: 10.1183/09031936.00183614

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
Chamira Rodrigo, Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Tricia M. Mckeever, Caroline L. Trotter, Mary Slack, Robert George, Wei Shen Lim
European Respiratory Journal Jun 2015, 45 (6) 1632-1641; DOI: 10.1183/09031936.00183614
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Method
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original Articles

  • Identifying early PAH biomarkers in systemic sclerosis
  • Viable virus aerosol propagation by PAP circuit leak
  • Ambulatory management of secondary spontaneous pneumothorax
Show more Original Articles

Respiratory infections

  • Biomarker assay to risk-stratify patients with respiratory tract infection
  • R. mucilaginosa is an anti-inflammatory in chronic lung disease
  • IMMUNOSUPPRESSANTS AND THE PROGNOSIS OF SARS-COV-2 INFECTION
Show more Respiratory infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society